This document summarizes research on the impact of glycemic control on diabetic patients with chronic kidney disease (CKD) requiring hemodialysis. It finds that poorer glycemic control, as indicated by higher HbA1c levels (>6.5%), is associated with lower estimated glomerular filtration rates (eGFR <6.5 ml/min/m2/year) and increased risk of CKD progression. Additionally, use of the oral hypoglycemic drug glipizide is linked to higher eGFR levels compared to other medications like metformin. The study highlights the importance of glycemic management for slowing CKD progression in diabetics undergoing hemodialysis.
This document summarizes research on the impact of glycemic control on diabetic patients with chronic kidney disease (CKD) requiring hemodialysis. It finds that poorer glycemic control, as indicated by higher HbA1c levels (>6.5%), is associated with lower estimated glomerular filtration rates (eGFR <6.5 ml/min/m2/year) and increased risk of CKD progression. Additionally, use of the oral hypoglycemic drug glipizide is linked to higher eGFR levels compared to other medications like metformin. The study highlights the importance of glycemic management for slowing CKD progression in diabetics undergoing hemodialysis.